<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Way_Of_Life._._Loss_And_Also_Olaparib</id>
		<title>Way Of Life. . Loss And Also Olaparib - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Way_Of_Life._._Loss_And_Also_Olaparib"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Way_Of_Life._._Loss_And_Also_Olaparib&amp;action=history"/>
		<updated>2026-05-03T16:24:54Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Way_Of_Life._._Loss_And_Also_Olaparib&amp;diff=197050&amp;oldid=prev</id>
		<title>Cell0linda: Створена сторінка: Retrospective chart analysis of 137 patients who underwent SDAF/SARS at a single institution. Patients were categorized as being at risk of renal damage when th...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Way_Of_Life._._Loss_And_Also_Olaparib&amp;diff=197050&amp;oldid=prev"/>
				<updated>2017-07-02T08:57:38Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Retrospective chart analysis of 137 patients who underwent SDAF/SARS at a single institution. Patients were categorized as being at risk of renal damage when th...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Retrospective chart analysis of 137 patients who underwent SDAF/SARS at a single institution. Patients were categorized as being at risk of renal damage when the maximum detrusor pressure was &amp;gt;40?cmH2O or detrusor compliance was [http://www.selleckchem.com/products/gsk1120212-jtp-74057.html Trametinib mw] of symptomatic UTI also decreased significantly (P?[http://www.selleckchem.com/products/AZD2281(Olaparib).html Olaparib research buy] surgical revision were observed. Defects of the stimulator cables or the receiver plate were the most common events (n?=?38). The retrospective design pertains to the limitations of the study. Sacral deafferentation and SARS are an effective treatment option for refractory NLUTD in patients with complete SCI, despite a substantial long-term complication rate. Neurourol. Urodynam. 33:1202�C1206, 2014. ? 2013 Wiley Periodicals, Inc. &amp;quot;&amp;quot;To investigate the functional outcome after supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction (NLUTD). Retrospective follow-up investigation in a single spinal [http://en.wikipedia.org/wiki/FKBPL FKBPL] cord injury rehabilitation center. In 29 patients, urodynamic data before and after supratrigonal cystectomy and augmentation ileocystoplasty, clinical outcome and post-operative complications were evaluated. The median age of the 29 patients at the time of surgery was 31 years, a median 14 years after NLUTD had occurred. At the last follow-up visit (median 2.4, range 0.4�C9.0 years post-operatively), 20/29 patients (69%) were continent compared to 2/29 pre-operatively (P?=?0.001). Furthermore, 16 patients required no or less detrusor relaxation therapy after augmentation ileocystoplasty. Augmentation cystoplasty resulted in a significant (P?=?0.001) increase in the median bladder capacity (from 240?ml to 500?ml) and compliance (from 13?ml/cm H2O to 50?ml/cm H2O). The median maximum detrusor pressure had decreased significantly (P?=?0.001) from 38?cm H2O to 15?cm H2O. Significantly (P?=?0.001) fewer patients presented with a risk for renal damage (1 vs. 15 with maximum detrusor pressure &amp;gt;40?cm H2O and 1 vs. 12 with detrusor compliance&lt;/div&gt;</summary>
		<author><name>Cell0linda</name></author>	</entry>

	</feed>